MA52900A - Inhibiteurs à petites molécules de la famille jak de kinases - Google Patents

Inhibiteurs à petites molécules de la famille jak de kinases

Info

Publication number
MA52900A
MA52900A MA052900A MA52900A MA52900A MA 52900 A MA52900 A MA 52900A MA 052900 A MA052900 A MA 052900A MA 52900 A MA52900 A MA 52900A MA 52900 A MA52900 A MA 52900A
Authority
MA
Morocco
Prior art keywords
kinases
small molecule
molecule inhibitors
jak family
jak
Prior art date
Application number
MA052900A
Other languages
English (en)
Inventor
Philippe Fernandes
Paul J Krawczuk
Mark S Tichenor
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA52900A publication Critical patent/MA52900A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
MA052900A 2018-06-15 2019-06-14 Inhibiteurs à petites molécules de la famille jak de kinases MA52900A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862685737P 2018-06-15 2018-06-15
US201962846290P 2019-05-10 2019-05-10

Publications (1)

Publication Number Publication Date
MA52900A true MA52900A (fr) 2021-04-21

Family

ID=67766195

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052900A MA52900A (fr) 2018-06-15 2019-06-14 Inhibiteurs à petites molécules de la famille jak de kinases

Country Status (23)

Country Link
US (3) US20200017498A1 (fr)
EP (1) EP3807277A1 (fr)
JP (1) JP2021528391A (fr)
KR (1) KR102768284B1 (fr)
CN (1) CN112313233A (fr)
AU (1) AU2019286641A1 (fr)
BR (1) BR112020024744A2 (fr)
CA (1) CA3101438A1 (fr)
CL (1) CL2020003227A1 (fr)
CO (1) CO2020015396A2 (fr)
CR (1) CR20200603A (fr)
EC (1) ECSP20080817A (fr)
IL (1) IL279314A (fr)
JO (1) JOP20200311A1 (fr)
MA (1) MA52900A (fr)
MX (1) MX2020013688A (fr)
NI (1) NI202000100A (fr)
PE (1) PE20212113A1 (fr)
PH (1) PH12020551984A1 (fr)
SG (1) SG11202011691PA (fr)
TW (1) TW202016110A (fr)
UY (1) UY38262A (fr)
WO (1) WO2019239387A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
JP7291077B2 (ja) 2016-12-16 2023-06-14 ヤンセン ファーマシューティカ エヌ．ベー． Ｊａｋファミリーのキナーゼの低分子阻害物質
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Ｊａｋ激酶家族之小分子抑制劑
MX2023010642A (es) 2021-03-11 2023-11-28 Janssen Pharmaceutica Nv Lorpucitinib para uso en el tratamiento de trastornos mediados por jak.
CN113292561A (zh) * 2021-05-22 2021-08-24 中国药科大学 一种二吡咯并吡啶结构的化合物、制备方法和医药用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
UA67844C2 (uk) 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP2005529933A (ja) 2002-05-31 2005-10-06 シェーリング　コーポレイション キサンチンホスホジエステラーゼｖインヒビター多形体
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
US7737279B2 (en) 2005-05-10 2010-06-15 Bristol-Myers Squibb Company 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
AU2006266045A1 (en) 2005-07-01 2007-01-11 Wyeth Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same
WO2007007919A2 (fr) 2005-07-14 2007-01-18 Astellas Pharma Inc. Nouveaux composes
CN102127078A (zh) 2005-07-14 2011-07-20 安斯泰来制药株式会社 Janus激酶3的杂环类抑制剂
CN104592231A (zh) 2008-06-10 2015-05-06 Abbvie公司 新的三环化合物
MX2012002480A (es) 2009-09-03 2012-03-26 Bristol Myers Squibb Co Inhibidores de jak2 y su uso en el tratamiento de enfermedades mieloproliferativas y cancer.
RU2711869C3 (ru) 2009-12-01 2022-02-02 Эббви Инк. Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
PH12012501000A1 (en) * 2009-12-01 2013-02-11 Abbvie Inc Novel tricyclic compounds
RU2012132278A (ru) * 2010-01-12 2014-02-20 Ф. Хоффманн-Ля Рош Аг Трициклические гетероциклические соединения, содержащие их композиции и способы их применения
AU2011214254B2 (en) 2010-02-10 2016-06-09 Genon Biotechnologies Oy Dual activity kinase domains and uses thereof
WO2013007765A1 (fr) * 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Composés tricycliques fusionnés utilisés en tant qu'inhibiteurs des janus kinases
GB201212081D0 (en) 2012-07-06 2012-08-22 Kalvista Pharmaceuticals Ltd New polymorph
JP6248948B2 (ja) 2013-02-08 2017-12-20 日産化学工業株式会社 ３環性ピロロピリジン化合物及びｊａｋ阻害剤
EP2924026A1 (fr) 2014-03-28 2015-09-30 Novartis Tiergesundheit AG Aminosulfonylméthylcyclohexanes comme inhibiteurs de JAK
BR112016023299A8 (pt) 2014-05-14 2021-06-29 Nissan Chemical Ind Ltd composto tricíclico e inibidor de jak, agente preventivo, terapêutico ou de melhoria para doenças contra as quais inibição de jak é eficaz e para artrite reumatoide, medicamento e utilização desses compostos
ES2753159T3 (es) 2015-05-28 2020-04-07 Theravance Biopharma R&D Ip Llc Compuestos de naftiridina como inhibidores de quinasa JAK
EP3371332A4 (fr) 2015-11-04 2019-04-03 Mayo Foundation for Medical Education and Research Méthodes et matériels pour traiter des maladies auto-immunes
JOP20190053A1 (ar) 2016-09-23 2019-03-21 Novartis Ag مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
EP3640251B1 (fr) 2016-10-24 2021-12-08 Astrazeneca AB Dérivés de 6,7,8,9-tétrahydro-3h-pyrazolo[4,3-f]isoquinoléine utiles dans le traitement du cancer
JOP20190144A1 (ar) * 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
KR102314286B1 (ko) 2016-12-16 2021-10-21 화이자 인코포레이티드 Glp-1 수용체 작용제 및 이의 용도
ES2941631T3 (es) 2016-12-16 2023-05-24 Lilly Co Eli Compuestos de Pirido[4,3-d][1,3]oxazin-2-ona como inhibidores de IDH1 e IDH2 mutantes
JP7291077B2 (ja) * 2016-12-16 2023-06-14 ヤンセン ファーマシューティカ エヌ．ベー． Ｊａｋファミリーのキナーゼの低分子阻害物質
EP3555050A1 (fr) 2016-12-16 2019-10-23 Basf Se Composés pesticides
WO2018109074A1 (fr) 2016-12-16 2018-06-21 Nestec Sa Oligosaccharides pour la génération d'arômes
LT3568396T (lt) 2017-01-11 2021-02-10 Leo Pharma A/S Nauji amino-imidazopiridino dariniai, kaip janus kinazės inhibitoriai ir jų farmacinis panaudojimas
PL3494116T3 (pl) 2017-01-30 2020-04-30 Astrazeneca Ab Modulatory receptora estrogenowego
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Ｊａｋ激酶家族之小分子抑制劑
WO2020216936A1 (fr) 2019-04-24 2020-10-29 Janssen Pharmaceutica Nv Formulations liquides non cliniques d'inhibiteur pan-jak

Also Published As

Publication number Publication date
ECSP20080817A (es) 2021-01-29
US11787807B2 (en) 2023-10-17
IL279314A (en) 2021-01-31
US20200017498A1 (en) 2020-01-16
CL2020003227A1 (es) 2021-05-14
NI202000100A (es) 2021-06-30
SG11202011691PA (en) 2020-12-30
WO2019239387A1 (fr) 2019-12-19
PE20212113A1 (es) 2021-11-04
CA3101438A1 (fr) 2019-12-19
UY38262A (es) 2019-12-31
EP3807277A1 (fr) 2021-04-21
KR102768284B1 (ko) 2025-02-13
US11066406B2 (en) 2021-07-20
CN112313233A (zh) 2021-02-02
MX2020013688A (es) 2021-02-26
TW202016110A (zh) 2020-05-01
BR112020024744A2 (pt) 2021-03-23
US20210340144A1 (en) 2021-11-04
CO2020015396A2 (es) 2021-03-08
US20200165250A1 (en) 2020-05-28
PH12020551984A1 (en) 2021-08-02
CR20200603A (es) 2021-01-20
KR20210021342A (ko) 2021-02-25
JP2021528391A (ja) 2021-10-21
JOP20200311A1 (ar) 2020-11-30
AU2019286641A1 (en) 2020-12-10

Similar Documents

Publication Publication Date Title
IL286487A (en) Technologies useful for oligonucleotide preparation
ZA201904615B (en) Small molecule inhibitors of the jak family of kinases
PL3829334T3 (pl) Podłoże wytwarzające aerozol
EP3889224A4 (fr) Revêtement anti-corrosion à base de graphène
PT3523390T (pt) Utilização de composições à base de tetrafluoropropeno
HUE060078T2 (hu) CDK7 gátlására alkalmas vegyületek
EP3852791A4 (fr) Activation de la pyruvate kinase r
MA52900A (fr) Inhibiteurs à petites molécules de la famille jak de kinases
EP3915338C0 (fr) Lampe à filament accordable en couleur
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
IL270693A (en) Glucuronide prodrugs of janus kinase inhibitors
EP3824778A4 (fr) Pomme de douche
PL3672965T3 (pl) Związek pirymidynowy jako inhibitor kinazy JAK
EP3411157A4 (fr) Revêtements résistants à la buée
EP3804707A4 (fr) Inhibiteur de kinase
PL3976597T3 (pl) Inhibitory małocząsteczkowe kinazy indukującej nf-kb
EP3849570A4 (fr) Compositions contenant du plasma sanguin
EP3768272A4 (fr) Inhibiteurs de jak
IL282114A (en) Processes for preparing functionalized cyclooctenes
EP3658683A4 (fr) Découverte d'épitopes à médiation par trogocytose
EP3556758A4 (fr) Inhibiteur de cdk4/6
IL280047A (en) Formulation of cannabinoid compounds
EP3966209A4 (fr) Inhibiteurs de jak
EP3763299A4 (fr) Instrument garrot
IL280025A (en) A xinafoate salt of a jak inhibiting compound